{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T19:47:18Z","timestamp":1778615238263,"version":"3.51.4"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplant Immunology"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1016\/j.trim.2019.101225","type":"journal-article","created":{"date-parts":[[2019,7,19]],"date-time":"2019-07-19T11:43:04Z","timestamp":1563536584000},"page":"101225","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Preliminary assessment of the feasibility of autologous myeloid-derived suppressor cell infusion in non-human primate kidney transplantation"],"prefix":"10.1016","volume":"56","author":[{"given":"Mohamed B.","family":"Ezzelarab","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angelica","family":"Perez-Gutierrez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abhinav","family":"Humar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"Wijkstrom","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alan F.","family":"Zahorchak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lien","family":"Lu-Casto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu-Chao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roger W.","family":"Wiseman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marta","family":"Minervini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angus W.","family":"Thomson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.trim.2019.101225_bb0005","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1038\/nri2137","article-title":"What does the future hold for cell-based tolerogenic therapy?","volume":"7","author":"Bluestone","year":"2007","journal-title":"Nat. Rev. Immunol."},{"issue":"8","key":"10.1016\/j.trim.2019.101225_bb0010","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1038\/nri2132","article-title":"Tolerogenic dendritic cells and the quest for transplant tolerance","volume":"7","author":"Morelli","year":"2007","journal-title":"Nat. Rev. Immunol."},{"issue":"6","key":"10.1016\/j.trim.2019.101225_bb0015","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1038\/nri3227","article-title":"Regulatory immune cells in transplantation","volume":"12","author":"Wood","year":"2012","journal-title":"Nat. Rev. Immunol."},{"issue":"304","key":"10.1016\/j.trim.2019.101225_bb0020","doi-asserted-by":"crossref","first-page":"304ps18","DOI":"10.1126\/scitranslmed.aaa7721","article-title":"Hurdles in therapy with regulatory T cells","volume":"7","author":"Trzonkowski","year":"2015","journal-title":"Sci. Transl. Med."},{"issue":"6","key":"10.1016\/j.trim.2019.101225_bb0025","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1038\/ki.2015.50","article-title":"Now or never? The case for cell-based immunosuppression in kidney transplantation","volume":"87","author":"Hutchinson","year":"2015","journal-title":"Kidney Int."},{"issue":"7","key":"10.1016\/j.trim.2019.101225_bb0030","doi-asserted-by":"crossref","first-page":"2505","DOI":"10.1172\/JCI90598","article-title":"Transplant trials with Tregs: perils and promises","volume":"127","author":"Tang","year":"2017","journal-title":"J. Clin. Invest."},{"issue":"2","key":"10.1016\/j.trim.2019.101225_bb0035","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1038\/s41590-017-0022-x","article-title":"Myeloid-derived suppressor cells coming of age","volume":"19","author":"Veglia","year":"2018","journal-title":"Nat. Immunol."},{"issue":"2","key":"10.1016\/j.trim.2019.101225_bb0040","doi-asserted-by":"crossref","first-page":"422","DOI":"10.4049\/jimmunol.1701019","article-title":"Myeloid-derived suppressor cells: immune-suppressive cells that impair antitumor immunity and are sculpted by their environment","volume":"200","author":"Ostrand-Rosenberg","year":"2018","journal-title":"J. Immunol."},{"key":"10.1016\/j.trim.2019.101225_bb0045","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms12150","article-title":"Recommendations for myeloid-derived suppressor cell nomenclature and characterization standards","volume":"7","author":"Bronte","year":"2016","journal-title":"Nat. Commun."},{"issue":"25","key":"10.1016\/j.trim.2019.101225_bb0050","doi-asserted-by":"crossref","first-page":"5738","DOI":"10.1182\/blood-2010-06-287839","article-title":"Bone marrow myeloid-derived suppressor cells (MDSCs) inhibit graft-versus-host disease (GVHD) via an arginase-1-dependent mechanism that is up-regulated by interleukin-13","volume":"116","author":"Highfill","year":"2010","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.trim.2019.101225_bb0055","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1172\/JCI41628","article-title":"Monocytic suppressive cells mediate cardiovascular transplantation tolerance in mice","volume":"120","author":"Garcia","year":"2010","journal-title":"J. Clin. Invest."},{"issue":"9","key":"10.1016\/j.trim.2019.101225_bb0060","doi-asserted-by":"crossref","first-page":"2034","DOI":"10.1111\/j.1600-6143.2009.02757.x","article-title":"Endotoxin-induced myeloid-derived suppressor cells inhibit alloimmune responses via heme oxygenase-1","volume":"9","author":"De Wilde","year":"2009","journal-title":"Am. J. Transplant."},{"issue":"7","key":"10.1016\/j.trim.2019.101225_bb0065","doi-asserted-by":"crossref","first-page":"3783","DOI":"10.4049\/jimmunol.1201449","article-title":"Myeloid-derived suppressor cells suppress antitumor immune responses through IDO expression and correlate with lymph node metastasis in patients with breast cancer","volume":"190","author":"Yu","year":"2013","journal-title":"J. Immunol."},{"issue":"12","key":"10.1016\/j.trim.2019.101225_bb0070","doi-asserted-by":"crossref","first-page":"7898","DOI":"10.4049\/jimmunol.180.12.7898","article-title":"Myeloid-derived suppressor cells accumulate in kidney allograft tolerance and specifically suppress effector T cell expansion","volume":"180","author":"Dugast","year":"2008","journal-title":"J. Immunol."},{"issue":"8","key":"10.1016\/j.trim.2019.101225_bb0075","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1097\/TP.0000000000001529","article-title":"C-C chemokine receptor type 2-dependent migration of myeloid-derived suppressor cells in protection of islet transplants","volume":"101","author":"Qin","year":"2017","journal-title":"Transplantation"},{"key":"10.1016\/j.trim.2019.101225_bb0080","doi-asserted-by":"crossref","first-page":"282","DOI":"10.3389\/fimmu.2018.00282","article-title":"Dexamethasone-induced myeloid-derived suppressor cells prolong allo cardiac graft survival through iNOS- and glucocorticoid receptor-dependent mechanism","volume":"9","author":"Zhao","year":"2018","journal-title":"Front. Immunol."},{"issue":"12","key":"10.1016\/j.trim.2019.101225_bb0085","doi-asserted-by":"crossref","first-page":"3123","DOI":"10.1111\/ajt.12461","article-title":"Monocytic myeloid-derived suppressor cells accumulate in renal transplant patients and mediate CD4(+) Foxp3(+) Treg expansion","volume":"13","author":"Luan","year":"2013","journal-title":"Am. J. Transplant."},{"issue":"10","key":"10.1016\/j.trim.2019.101225_bb0090","doi-asserted-by":"crossref","first-page":"2544","DOI":"10.1111\/ajt.14718","article-title":"Myeloid-derived suppressor cells increase and inhibit donor-reactive T cell responses to graft intestinal epithelium in intestinal transplant patients","volume":"18","author":"Okano","year":"2018","journal-title":"Am. J. Transplant."},{"issue":"8","key":"10.1016\/j.trim.2019.101225_bb0095","doi-asserted-by":"crossref","first-page":"4233","DOI":"10.1182\/blood-2007-07-099226","article-title":"Identification of discrete tumor-induced myeloid-derived suppressor cell subpopulations with distinct T cell-suppressive activity","volume":"111","author":"Movahedi","year":"2008","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.trim.2019.101225_bb0100","doi-asserted-by":"crossref","first-page":"5791","DOI":"10.4049\/jimmunol.181.8.5791","article-title":"Subsets of myeloid-derived suppressor cells in tumor-bearing mice","volume":"181","author":"Youn","year":"2008","journal-title":"J. Immunol."},{"issue":"1","key":"10.1016\/j.trim.2019.101225_bb0105","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1002\/eji.200939903","article-title":"Hierarchy of immunosuppressive strength among myeloid-derived suppressor cell subsets is determined by GM-CSF","volume":"40","author":"Dolcetti","year":"2010","journal-title":"Eur. J. Immunol."},{"issue":"3","key":"10.1016\/j.trim.2019.101225_bb0110","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1097\/TP.0000000000002022","article-title":"Myeloid-derived suppressor cells and their potential application in transplantation","volume":"102","author":"Scalea","year":"2018","journal-title":"Transplantation"},{"key":"10.1016\/j.trim.2019.101225_bb0115","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1034\/j.1600-065x.2001.1830117.x","article-title":"Preclinical evaluation of tolerance induction protocols and islet transplantation in non-human primates","volume":"183","author":"Montgomery","year":"2001","journal-title":"Immunol. Rev."},{"issue":"3","key":"10.1016\/j.trim.2019.101225_bb0120","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.trre.2019.03.002","article-title":"Transplant research in nonhuman primates to evaluate clinically relevant immune strategies in organ transplantation","volume":"33","author":"Fitch","year":"2019","journal-title":"Transplant. Rev."},{"issue":"2","key":"10.1016\/j.trim.2019.101225_bb0125","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1111\/ajt.13454","article-title":"In vivo mobilization and functional characterization of nonhuman primate monocytic myeloid-derived suppressor cells","volume":"16","author":"Zahorchak","year":"2016","journal-title":"Am. J. Transplant."},{"issue":"8","key":"10.1016\/j.trim.2019.101225_bb0130","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1111\/ajt.12310","article-title":"Regulatory dendritic cell infusion prolongs kidney allograft survival in nonhuman primates","volume":"13","author":"Ezzelarab","year":"2013","journal-title":"Am. J. Transplant."},{"issue":"1","key":"10.1016\/j.trim.2019.101225_bb0135","first-page":"70","article-title":"Leukapheresis protocol for nonhuman primates weighing less than 10 kg","volume":"52","author":"Pathiraja","year":"2013","journal-title":"J. Am. Assoc. Lab. Anim. Sci."},{"issue":"7","key":"10.1016\/j.trim.2019.101225_bb0140","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1111\/ajt.13685","article-title":"Regulatory T cell infusion can enhance memory T cell and alloantibody responses in lymphodepleted nonhuman primate heart allograft recipients","volume":"16","author":"Ezzelarab","year":"2016","journal-title":"Am. J. Transplant."},{"issue":"1","key":"10.1016\/j.trim.2019.101225_bb0145","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1093\/ndt\/gfr264","article-title":"Renal transplant recipients have elevated frequencies of circulating myeloid-derived suppressor cells","volume":"27","author":"Hock","year":"2012","journal-title":"Nephrol. Dial. Transplant."},{"issue":"6","key":"10.1016\/j.trim.2019.101225_bb0150","doi-asserted-by":"crossref","first-page":"2538","DOI":"10.1172\/JCI73518","article-title":"Vaccine-induced myeloid cell population dampens protective immunity to SIV","volume":"124","author":"Sui","year":"2014","journal-title":"J. Clin. Invest."},{"issue":"9","key":"10.1016\/j.trim.2019.101225_bb0155","doi-asserted-by":"crossref","first-page":"2350","DOI":"10.1111\/ajt.14350","article-title":"Increased pretransplant frequency of CD28(+) CD4(+) TEM predicts belatacept-resistant rejection in human renal transplant recipients","volume":"17","author":"Cortes-Cerisuelo","year":"2017","journal-title":"Am. J. Transplant."},{"issue":"9","key":"10.1016\/j.trim.2019.101225_bb0160","doi-asserted-by":"crossref","first-page":"2285","DOI":"10.1111\/ajt.14349","article-title":"Belatacept-resistant rejection is associated with CD28(+) memory CD8 T cells","volume":"17","author":"Mathews","year":"2017","journal-title":"Am. J. Transplant."},{"issue":"1","key":"10.1016\/j.trim.2019.101225_bb0165","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1097\/TP.0000000000000871","article-title":"Eomesoderminlo CTLA4hi alloreactive CD8+ memory T cells are associated with prolonged renal transplant survival induced by regulatory dendritic cell infusion in CTLA4 immunoglobulin-treated nonhuman primates","volume":"100","author":"Ezzelarab","year":"2016","journal-title":"Transplantation"},{"issue":"1","key":"10.1016\/j.trim.2019.101225_bb0170","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.it.2010.10.002","article-title":"Molecular mechanisms regulating myeloid-derived suppressor cell differentiation and function","volume":"32","author":"Condamine","year":"2011","journal-title":"Trends Immunol."},{"issue":"2","key":"10.1016\/j.trim.2019.101225_bb0175","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2015.1004983","article-title":"Phenotype, development, and biological function of myeloid-derived suppressor cells","volume":"5","author":"Zhao","year":"2016","journal-title":"Oncoimmunology"},{"issue":"4","key":"10.1016\/j.trim.2019.101225_bb0180","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1038\/nri3175","article-title":"Coordinated regulation of myeloid cells by tumours","volume":"12","author":"Gabrilovich","year":"2012","journal-title":"Nat. Rev. Immunol."},{"issue":"7","key":"10.1016\/j.trim.2019.101225_bb0185","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/j.intimp.2011.01.026","article-title":"MDSC in autoimmunity","volume":"11","author":"Cripps","year":"2011","journal-title":"Int. Immunopharmacol."},{"issue":"2","key":"10.1016\/j.trim.2019.101225_bb0190","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1007\/s40472-015-0054-9","article-title":"Monocyte-derived suppressor cells in transplantation","volume":"2","author":"Ochando","year":"2015","journal-title":"Curr. Transpl. Rep."},{"issue":"24","key":"10.1016\/j.trim.2019.101225_bb0195","doi-asserted-by":"crossref","first-page":"2651","DOI":"10.1182\/blood-2017-11-785865","article-title":"Immune regulatory cell infusion for graft-versus-host disease prevention and therapy","volume":"131","author":"Blazar","year":"2018","journal-title":"Blood"},{"issue":"9","key":"10.1016\/j.trim.2019.101225_bb0200","doi-asserted-by":"crossref","first-page":"2364","DOI":"10.1111\/ajt.13276","article-title":"Rapamycin prolongs cardiac allograft survival in a mouse model by inducing myeloid-derived suppressor cells","volume":"15","author":"Nakamura","year":"2015","journal-title":"Am. J. Transplant."},{"issue":"3","key":"10.1016\/j.trim.2019.101225_bb0205","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1097\/TP.0b013e31823ffd39","article-title":"Myeloid-derived suppressor cells protect islet transplants by B7-H1 mediated enhancement of T regulatory cells","volume":"93","author":"Chou","year":"2012","journal-title":"Transplantation"},{"issue":"1","key":"10.1016\/j.trim.2019.101225_bb0210","doi-asserted-by":"crossref","first-page":"335","DOI":"10.4049\/jimmunol.180.1.335","article-title":"Macrophages driven to a novel state of activation have anti-inflammatory properties in mice","volume":"180","author":"Brem-Exner","year":"2008","journal-title":"J. Immunol."},{"issue":"2","key":"10.1016\/j.trim.2019.101225_bb0215","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1038\/mt.2012.168","article-title":"IFN-gamma-induced iNOS expression in mouse regulatory macrophages prolongs allograft survival in fully immunocompetent recipients","volume":"21","author":"Riquelme","year":"2013","journal-title":"Mol. Ther."},{"issue":"5","key":"10.1016\/j.trim.2019.101225_bb0220","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1097\/00007890-199609150-00021","article-title":"Costimulatory molecule-deficient dendritic cell progenitors (MHC class II+, CD80dim, CD86\u2212) prolong cardiac allograft survival in nonimmunosuppressed recipients","volume":"62","author":"Fu","year":"1996","journal-title":"Transplantation"},{"issue":"7","key":"10.1016\/j.trim.2019.101225_bb0225","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1002\/1521-4141(200007)30:7<1813::AID-IMMU1813>3.0.CO;2-8","article-title":"Immature dendritic cells generated with low doses of GM-CSF in the absence of IL-4 are maturation resistant and prolong allograft survival in vivo","volume":"30","author":"Lutz","year":"2000","journal-title":"Eur. J. Immunol."},{"issue":"13","key":"10.1016\/j.trim.2019.101225_bb0230","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1182\/blood-2015-03-634691","article-title":"GVHD-associated, inflammasome-mediated loss of function in adoptively transferred myeloid-derived suppressor cells","volume":"126","author":"Koehn","year":"2015","journal-title":"Blood"},{"issue":"14","key":"10.1016\/j.trim.2019.101225_bb0235","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1182\/bloodadvances.2017006858","article-title":"Novel GM-CSF signals via IFN-gammaR\/IRF-1 and AKT\/mTOR license monocytes for suppressor function","volume":"1","author":"Ribechini","year":"2017","journal-title":"Blood Adv."},{"issue":"3","key":"10.1016\/j.trim.2019.101225_bb0240","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1002\/stem.301","article-title":"Development and function of myeloid-derived suppressor cells generated from mouse embryonic and hematopoietic stem cells","volume":"28","author":"Zhou","year":"2010","journal-title":"Stem Cells"},{"key":"10.1016\/j.trim.2019.101225_bb0245","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.cellimm.2018.04.013","article-title":"Monocytic myeloid-derived suppressor cells generated from rhesus macaque bone marrow enrich for regulatory T cells","volume":"329","author":"Zahorchak","year":"2018","journal-title":"Cell. Immunol."},{"issue":"281","key":"10.1016\/j.trim.2019.101225_bb0250","doi-asserted-by":"crossref","first-page":"281ra42","DOI":"10.1126\/scitranslmed.3010435","article-title":"G-CSF mobilizes CD34+ regulatory monocytes that inhibit graft-versus-host disease","volume":"7","author":"D\u2019Aveni","year":"2015","journal-title":"Sci. Transl. Med."},{"issue":"10","key":"10.1016\/j.trim.2019.101225_bb0255","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1097\/TP.0000000000001315","article-title":"Comparative study of the immunoregulatory capacity of in vitro generated tolerogenic dendritic cells, suppressor macrophages, and myeloid-derived suppressor cells","volume":"100","author":"Carretero-Iglesia","year":"2016","journal-title":"Transplantation"}],"container-title":["Transplant Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0966327419300620?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0966327419300620?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T17:59:31Z","timestamp":1760810371000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0966327419300620"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10]]},"references-count":51,"alternative-id":["S0966327419300620"],"URL":"https:\/\/doi.org\/10.1016\/j.trim.2019.101225","relation":{},"ISSN":["0966-3274"],"issn-type":[{"value":"0966-3274","type":"print"}],"subject":[],"published":{"date-parts":[[2019,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Preliminary assessment of the feasibility of autologous myeloid-derived suppressor cell infusion in non-human primate kidney transplantation","name":"articletitle","label":"Article Title"},{"value":"Transplant Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.trim.2019.101225","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"101225"}}